Intellia Therapeutics, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Intellia Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2015 to Q3 2024.
  • Intellia Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$136M, a 11% decline year-over-year.
  • Intellia Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$522M, a 12.9% decline year-over-year.
  • Intellia Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$481M, a 1.48% decline from 2022.
  • Intellia Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$474M, a 77% decline from 2021.
  • Intellia Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$268M, a 99.6% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$522M -$136M -$13.5M -11% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$509M -$147M -$23.3M -18.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-07
Q1 2024 -$486M -$107M -$4.31M -4.18% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-07
Q4 2023 -$481M -$132M -$18.8M -16.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 -$462M -$122M -$9M -7.94% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$453M -$124M -$23M -22.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-07
Q1 2023 -$430M -$103M +$43.7M +29.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-07
Q4 2022 -$474M -$113M -$32.2M -39.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 -$442M -$113M -$41.6M -58% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$400M -$101M -$31.9M -46.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-09
Q1 2022 -$369M -$147M -$101M -218% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-09
Q4 2021 -$268M -$81.2M -$39M -92.5% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 -$229M -$71.6M -$43.8M -157% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$185M -$68.8M -$36.4M -112% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-03
Q1 2021 -$149M -$46.2M -$14.4M -45.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-03
Q4 2020 -$134M -$42.2M -$13.9M -49.2% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-26
Q3 2020 -$120M -$27.8M -$4.21M -17.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$116M -$32.4M -$6.71M -26.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-04
Q1 2020 -$109M -$31.8M -$9.87M -45% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-04
Q4 2019 -$99.5M -$28.3M -$9.21M -48.3% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-26
Q3 2019 -$90.3M -$23.6M -$932K -4.11% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-26
Q2 2019 -$89.4M -$25.7M -$3.46M -15.6% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-26
Q1 2019 -$85.9M -$21.9M -$584K -2.74% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-26
Q4 2018 -$85.3M -$19.1M +$4.9M +20.4% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-27
Q3 2018 -$90.2M -$22.7M -$7.35M -47.8% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-27
Q2 2018 -$82.9M -$22.2M -$6.63M -42.5% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-27
Q1 2018 -$76.3M -$21.4M -$8.73M -69.1% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-27
Q4 2017 -$67.5M -$24M -$13.4M -127% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-27
Q3 2017 -$54.1M -$15.4M -$7.87M -105% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-27
Q2 2017 -$46.3M -$15.6M -$8.69M -126% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-27
Q1 2017 -$37.6M -$12.6M -$5.94M -88.8% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-27
Q4 2016 -$31.6M -$10.6M -$5.32M -101% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-14
Q3 2016 -$26.3M -$7.48M -$4.46M -148% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-14
Q2 2016 -$21.9M -$6.9M -$3.86M -127% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-14
Q1 2016 -$18M -$6.69M -$5.6M -512% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-14
Q4 2015 -$12.4M -$5.25M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-14
Q3 2015 -$3.02M Jul 1, 2015 Sep 30, 2015 10-K 2017-03-14
Q2 2015 -$3.04M Apr 1, 2015 Jun 30, 2015 10-K 2017-03-14
Q1 2015 -$1.09M Jan 1, 2015 Mar 31, 2015 10-K 2017-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.